Shalby [SHALBY] vs Dr. Agarwal's Eye [DRAGARWQ] Detailed Stock Comparison
Shalby
NSE
Loading...
Dr. Agarwal's Eye
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Shalby wins in 7 metrics, Dr. Agarwal's Eye wins in 13 metrics, with 0 ties. Dr. Agarwal's Eye appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Shalby | Dr. Agarwal's Eye | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 1,126.78 | 37.83 | Dr. Agarwal's Eye |
| Price-to-Book Ratio | 1.99 | 9.87 | Shalby |
| Debt-to-Equity Ratio | 9.69 | 158.94 | Shalby |
| PEG Ratio | 21.58 | 452.67 | Shalby |
| EV/EBITDA | 13.36 | 20.08 | Shalby |
| Profit Margin (TTM) | 0.57% | 13.76% | Dr. Agarwal's Eye |
| Operating Margin (TTM) | 1.74% | 21.43% | Dr. Agarwal's Eye |
| EBITDA Margin (TTM) | 1.74% | 21.43% | Dr. Agarwal's Eye |
| Return on Equity | 0.19% | 29.80% | Dr. Agarwal's Eye |
| Return on Assets (TTM) | 2.52% | 8.91% | Dr. Agarwal's Eye |
| Free Cash Flow (TTM) | $-757.89M | $-83.80M | Dr. Agarwal's Eye |
| Dividend Yield | 0.65% | 0.11% | Shalby |
| 1-Year Return | -23.68% | 14.28% | Dr. Agarwal's Eye |
| Price-to-Sales Ratio (TTM) | 2.00 | 5.21 | Shalby |
| Enterprise Value | $17.72B | $23.79B | Dr. Agarwal's Eye |
| EV/Revenue Ratio | 1.63 | 5.99 | Shalby |
| Gross Profit Margin (TTM) | 37.50% | 58.37% | Dr. Agarwal's Eye |
| Revenue per Share (TTM) | $112 | $845 | Dr. Agarwal's Eye |
| Earnings per Share (Diluted) | $0.18 | $116.30 | Dr. Agarwal's Eye |
| Beta (Stock Volatility) | 0.46 | -0.35 | Dr. Agarwal's Eye |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Shalby vs Dr. Agarwal's Eye Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Shalby | 1.16% | -0.41% | 12.24% | 9.45% | -0.03% | -10.88% |
| Dr. Agarwal's Eye | -1.47% | 3.27% | 1.73% | 11.57% | 15.69% | -30.24% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Shalby | -23.68% | 59.89% | 132.06% | -15.35% | -15.35% | -15.35% |
| Dr. Agarwal's Eye | 14.28% | 471.47% | 1,869.17% | 3,014.69% | 5,475.68% | 10,378.65% |
Performance & Financial Health Analysis: Shalby vs Dr. Agarwal's Eye
| Metric | SHALBY | DRAGARWQ |
|---|---|---|
| Market Information | ||
| Market Cap | ₹21.76B | ₹20.68B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 201,770 | 1,388 |
| 90 Day Avg. Volume | 320,175 | 1,413 |
| Last Close | ₹208.37 | ₹4,449.75 |
| 52 Week Range | ₹177.25 - ₹297.90 | ₹3,500.00 - ₹7,300.00 |
| % from 52W High | -30.05% | -39.04% |
| All-Time High | ₹339.50 (Jan 22, 2024) | ₹7,300.00 (Dec 30, 2024) |
| % from All-Time High | -38.62% | -39.04% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.09% | 0.21% |
| Quarterly Earnings Growth | 0.11% | 0.25% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.14% |
| Operating Margin (TTM) | 0.02% | 0.21% |
| Return on Equity (TTM) | 0.00% | 0.30% |
| Debt to Equity (MRQ) | 9.69 | 158.94 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹101.79 | ₹445.96 |
| Cash per Share (MRQ) | ₹32.80 | ₹52.76 |
| Operating Cash Flow (TTM) | ₹-43,430,000 | ₹944.80M |
| Levered Free Cash Flow (TTM) | ₹-887,275,008 | ₹-279,437,504 |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.65% | 0.11% |
| Last 12-Month Dividend | ₹1.20 | ₹5.00 |
Valuation & Enterprise Metrics Analysis: Shalby vs Dr. Agarwal's Eye
| Metric | SHALBY | DRAGARWQ |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 1,126.78 | 37.83 |
| Forward P/E | 21.58 | 452.67 |
| PEG Ratio | 21.58 | 452.67 |
| Price to Sales (TTM) | 2.00 | 5.21 |
| Price to Book (MRQ) | 1.99 | 9.87 |
| Market Capitalization | ||
| Market Capitalization | ₹21.76B | ₹20.68B |
| Enterprise Value | ₹17.72B | ₹23.79B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.63 | 5.99 |
| Enterprise to EBITDA | 13.36 | 20.08 |
| Risk & Other Metrics | ||
| Beta | 0.46 | -0.35 |
| Book Value per Share (MRQ) | ₹101.79 | ₹445.96 |
Financial Statements Comparison: Shalby vs Dr. Agarwal's Eye
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SHALBY | DRAGARWQ |
|---|---|---|
| Revenue/Sales | ₹2.65B | ₹998.30M |
| Cost of Goods Sold | ₹1.66B | ₹415.60M |
| Gross Profit | ₹993.23M | ₹582.70M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹46.11M | ₹213.90M |
| EBITDA | ₹261.61M | ₹316.90M |
| Pre-Tax Income | ₹-7.38M | ₹186.00M |
| Income Tax | ₹114.50M | ₹26.10M |
| Net Income (Profit) | ₹-121.88M | ₹159.90M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SHALBY | DRAGARWQ |
|---|---|---|
| Cash & Equivalents | ₹347.85M | ₹111.60M |
| Total Current Assets | ₹6.58B | ₹559.40M |
| Total Current Liabilities | ₹4.55B | ₹869.80M |
| Long-Term Debt | ₹1.75B | ₹3.06B |
| Total Shareholders Equity | ₹9.95B | ₹2.10B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹8.88B | ₹3.65B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SHALBY | DRAGARWQ |
|---|---|---|
| Operating Cash Flow | ₹433.19M | N/A |
| Capital Expenditures | ₹-563.59M | N/A |
| Free Cash Flow | ₹-66.61M | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SHALBY | DRAGARWQ |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 201,770 | 1,388 |
| Average Daily Volume (90 Day) | 320,175 | 1,413 |
| Shares Outstanding | 107.27M | 4.70M |
| Float Shares | 24.09M | 1.11M |
| % Held by Insiders | 0.67% | 0.78% |
| % Held by Institutions | 0.00% | 0.02% |
Dividend Analysis & Yield Comparison: Shalby vs Dr. Agarwal's Eye
| Metric | SHALBY | DRAGARWQ |
|---|---|---|
| Last 12-Month Dividend | ₹1.20 | ₹5.00 |
| Last 12-Month Dividend Yield | 0.65% | 0.11% |
| 3-Year Avg Annual Dividend | ₹1.08 | ₹4.50 |
| 3-Year Avg Dividend Yield | 0.55% | 0.12% |
| 3-Year Total Dividends | ₹3.23 | ₹13.50 |
| Ex-Dividend Date | Sep 19, 2024 | Nov 08, 2024 |